Inamed v. Ethicon Endo-Surgery
This article was originally published in The Gray Sheet
Executive Summary
Trial date for Inamed's royalty dispute with Dr. Lubomyr Kuzmak and Johnson & Johnson/Ethicon Endo-Surgery, regarding patents related to Inamed's LapBand gastric band obesity device,will be set by September. The trial will probably begin by the end of the year, according to Inamed. On June 18, a Los Angeles federal court ruled that a January 2000 settlement, establishing a licensing agreement between Inamed and Kuzmak, was unenforceable. While the original patent suit will move forward, Inamed hopes the settlement can be restored following an appeal of the June 18 decision...
You may also be interested in...
Ethicon/Obtech
Johnson & Johnson's Ethicon Endo-Surgery unit gains Swedish Adjustable Gastric Band laparoscopic surgical device for treatment of morbid obesity through June 27 purchase of Obtech Medical AG. The SAGB system has been available in Europe since 1987, but U.S. commercialization plans have not been finalized. Ethicon owns patents originally held by Lubomyr Kuzmak, MD, related to gastric band technology similar to the SAGB, but they are the subject of infringement litigation by Lap-Band maker Inamed (1"The Gray Sheet" June 24, 2002, In Brief)...
US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios
Forthcoming guidance is expected to describe areas of “low-hanging fruit” and those that are more challenging for use of the expedited pathway, Center for Biologics Evaluation and Research Director Peter Marks said.
FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Kahn Says
The agency is also poised to announce another development in its scrutiny of the drug patents listed in the FDA’s Orange Book.